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author and source are credited.Dual functionality of O-GlcNAc transferase
is required for Drosophila development
Daniel Mariappa1, Xiaowei Zheng1, Marianne Schimpl1, Olawale Raimi2,
Andrew T. Ferenbach1, H.-Arno J. Mu¨ller3 and Daan M. F. van Aalten1,2
1MRC Protein Phosphorylation and Ubiquitylation Unit, 2Division of Molecular Microbiology, and 3Division of
Cell and Developmental Biology, College of Life Sciences, University of Dundee, Dundee, UK
Post-translational modification of intracellular proteins with O-linked
N-acetylglucosamine (O-GlcNAc) catalysed by O-GlcNAc transferase (OGT)
has been linked to regulation of diverse cellular functions. OGT possesses a
C-terminal glycosyltransferase catalytic domain andN-terminal tetratricopep-
tide repeats that are implicated in protein–protein interactions. Drosophila
OGT (DmOGT) is encoded by super sex combs (sxc), mutants of which are
pupal lethal. However, it is not clear if this phenotype is caused by reduction
ofO-GlcNAcylation. Herewe use a genetic approach to demonstrate that post-
pupal Drosophila development can proceed with negligible OGT catalysis,
while early embryonic development is OGT activity-dependent. Structural
and enzymatic comparison between human OGT (hOGT) and DmOGT
informed the rational design of DmOGT point mutants with a range of
reduced catalytic activities. Strikingly, a severely hypomorphic OGT mutant
complements sxc pupal lethality. However, the hypomorphic OGT mutant-
rescued progeny do not produce F2 adults, because a set of Hox genes is
de-repressed in F2 embryos, resulting in homeotic phenotypes. Thus, OGT
catalytic activity is required up to late pupal stages, while further development
proceeds with severely reduced OGT activity.1. Introduction
Post-translational modification of more than 1000 proteins with O-linked N-acet-
ylglucosamine (O-GlcNAc) has been shown to affect a diverse array of cellular
functions in metazoa, including protein stability, intracellular localization,
protein–protein interaction, phosphorylation and ubiquitylation [1–3]. The
enzyme that catalyses the addition of a single GlcNAc onto serine/threonine
residues on intracellular proteins is O-GlcNAc transferase (OGT). OGT is
highly conserved in metazoa, consisting of a C-terminal glycosyltransferase
domain and N-terminal tetratricopeptide repeats (TPRs). Recent studies on the
structure of the catalytic domain of humanOGT (hOGT) have provided an insight
into the mechanism of catalysis and protein substrate recognition [4–6]. TPRs are
34-amino acid helical protein–protein interaction motifs that are typically clus-
tered in 3–16 repeats. TPR motif-containing proteins participate in a diverse
array of functions, often as part of multi-protein complexes [7]. In hOGT, the
TPRs adopt a right-hand super-helical conformation protruding away from
the catalytic domain [5,8]. This TPR super-helix creates a large surface area that
is thought to allow OGT to interact with a variety of protein substrates. Most
OGT interactors require its TPRs for binding, for instance GRIF-1, OIP106 [9],
Sin3A [10] and TET2 [11], while some others interact with the C-terminal
domain as in the case of MAPK [12]. OGT isoforms possessing varying numbers
of TPRs or recombinant OGT lacking the full complement of TPRs have distinct
substrate preferences [13,14]. However, there is no evidence implicating the invol-
vement of OGT in an interaction that does not ultimately invoke its catalytic
activity. Nevertheless, it is plausible that proteins interacting only with the
most N-terminal TPRs of OGT are non-substrate interactors.
Table 1. Data collection and reﬁnement statistics (values in brackets are
those for the highest resolution bin).
DmOGTK872M
space group P32
cell dimensions
a ¼ b, c (A˚) 160.95, 77.19
resolution (A˚) 50.00—2.66 (2.75—2.66)
Rmerge 0.121 (0.916)
CC1/2 0.996 (0.627)
//s/ 8.8 (1.5)
completeness (%) 99.7 (99.1)
redundancy 5.1 (4.9)
no. reﬂections 327 309
Rwork/Rfree 0.225/0.264
no. atoms
protein 16 023
UDP-5S-GlcNAc 114
water 99
average B-factors
protein 50.8
UDP-5S-GlcNAc 39.5
water 37.5
RMSD from ideal geometry
bond lengths (A˚) 0.008
bond angles (8) 1.26
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except zebrafish, which has two [15]. In several animal
models, it has been shown that ogt is essential for embryogen-
esis and early development. ogt null mice are embryonic lethal,
while tissue-specific ogt knock out in T cells, fibroblasts and
neurons results in severe phenotypic abnormalities and perina-
tal death [16,17]. ogtknockdown in zebrafish andXenopus laevis
embryos produces severe growth defects, shortened body axis
and retarded nervous system development [18,19]. In
Drosophila, ogt is known as super sex combs (sxc), mutants of
which do not develop beyond the pharate adult stage. sxc
belongs to the Polycomb group (PcG) genes that play key roles
in developmental regulation, stem-cell maintenance and
genomic imprinting [20–22]. In Caenorhabditis elegans, animals
homozygous for a partial deletion of ogt-1 are viable and fertile
[23]. In Arabidopsis, unlike animal genomes, there are two
genes, SPINDLY (SPY) and SECRET AGENT (SEC) coding
for OGT with both overlapping and distinct functions.
Double mutants of these OGT genes are embryonic lethal [24].
Many of the above studies used genetic approaches
designed to generate organisms that are OGT protein null.
Transheterozygotic Drosophila larvae with an sxc1 allele have
been reported to possess low levels of expression of a truncated
form (lacking the C-terminal 165 amino acids) of OGT [20].
Another sxc allele, sxc6, is a protein null mutant. Larvae carry-
ing two other sxc alleles, sxc4 and sxc5, also express mutant
OGTs at levels comparable with the wild-type [20,22]. These
alleles carry a point mutation (N948I; sxc4) or a 19-amino acid
C terminal deletion (D1031–1059; sxc5). The phenotypes of
the sxc4 and sxc5 alleles are as severe as the null mutants,
suggesting a role for the OGT catalytic domain in Drosophila
development. While the catalytic activity of DmOGTD1031–1059
has not been assessed, larval lysate from sxc4/sxc4 possesses
catalytic activity comparable with that of sxc2637/sxc2637, an
OGT null mutant. Given the lack of mutant OGTs with
impaired catalytic activity, phenotypes associated with partial
loss of O-GlcNAc levels have not been explored.
Here, we use Drosophila melanogaster as a model organism
to investigate the dependence of developmental pathways on
O-GlcNAcylation. The structural and catalytic similarities
between human OGT (hOGT) and DmOGT (DmOGT) were
investigated using protein crystallography and enzymology.
Structure-guided mutagenesis led to the identification of OGT
mutants with varying levels of catalytic activity leading to
generation of transgenic flies expressing catalytically impaired
DmOGTs. Strikingly, pupal lethality observed in sxc mutants
was rescued by overexpressing either the OGTWT or the cataly-
tically inactive OGTD955A mutant. However, the sxc F1 progeny
rescued with OGTD955A do not produce any F2 adults.
F2 embryos from OGTD955A rescue display derepression of a
subset ofHox genes. These experiments reveal thatOGTactivity
is required for development to pupal stages, while a severely
hypomorphic form of OGT is sufficient to support later
developmental processes dependent on zygotic sxc products.2. Results
2.1. DmOGT is structurally similar to hOGT
Sequence similarity between hOGT and DmOGT is high, with
90% and approximately 80% sequence identity in the TPR
region and the catalytic domain, respectively. Themost variabledomain is the ‘intervening domain’, a 100-amino acid insertion
between the two Rossmann-folds that constitute the catalytic
domain, the sequence identity being only 39%. No function
has been attributed to the interveningdomain despite structural
information being available [5]. Additionally, the patch of basic
residues (contained within hOGT 958–1001) proposed to inter-
act with phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) is not
conserved in DmOGT.
To determine how differences in sequence influence the
overall structure ofDmOGTand toprovide a template for struc-
ture-guided mutagenesis, an N-terminally truncated construct
starting at amino acid 353 in TPR 10 (D1–352) carrying a
mutation (K872M) of a key catalytic lysine was expressed in
Escherichia coli and crystallized in complex with the inhibitor/
substrate analogue UDP-5S-GlcNAc. The structure was
solved bymolecular replacement and refined against 2.7 A˚ syn-
chrotron diffraction data (table 1), yielding clear electron
density for UDP-5S-GlcNAc (figure 1a,b). It appears that
DmOGT adopts the canonical OGT fold with the bilobal
arrangement of two Rossmann-like domains characteristic of
the GT-B superfamily of glycosyltransferases, as well as the
additional TPR-like helices (535–566) in the N-terminal of the
catalytic domain, which lead into the TPR domain (figure 1a).
As a result, the TPRs are in close association with the glycosyl-
transferase domain and the catalytic site is aligned with the
channel along the main axis of the TPR superhelix. Superposi-
tion of the catalytic domain ofDmOGTwith the reportedhOGT
structure (PDBID 3PE4 (5)) highlights the structural similarities
K4872M H537
Q869
T598
100
IC50
80
60
ac
tiv
ity
 (%
)
ac
tiv
ity
 (%
)
40
20
10–8 10–6 10–4 10–2
0
100 60 000
H537A
H596F
K872M, D955A
(no activity)
time (h)
0 3 6 9 12
40 000
D
PM
ac
iti
v
ity
 (%
)
20 000
0
80
60
40
20
0
wt H537A H596F K872M D955A
2 4 6
UDP-GlcNAc (×10–5 M) UDP-5SGlcNAc (M)
hOGT
hOGT
hOGTKm 6.6 ± 0.3 µm 17.8 ± 0.7 µm
68.3 µm
24.6 µm
DmOGT
hOGT
DmOGT
DmOGT DmOGT
8 10
100
(a)
(d)
(b) (c)
(e)
( f ) (g)
80
60
40
20
0
Figure 1. Structural and enzymatic characterization of DmOGT. (a) DmOGT adopts the canonical OGT fold with the intervening domain (ID, yellow surface) and the
TPR repeats (grey surface) closely associated with the glycosyltransferase domain (green and pink surfaces). The donor substrate analogue UDP-5S-GlcNAc is shown
as sticks with black carbons. (b) A close-up view of the catalytic site of DmOGT with UDP-5S-GlcNAc shown as sticks with black carbon atoms. Unbiased Fo-Fc electron
density for the ligand is shown as pink mesh, contoured at 2.5 s. The acceptor peptide TAB1tide from a superimposed hOGT structure (PDBID: 4AY6(6)) is shown as
sticks with yellow carbon atoms. (c) The surface of DmOGT coloured by sequence conservation with hOGT. Identical residues are shaded in blue, and non-conserved
residues are shown in white. (d ) Michaelis–Menten constants (Km) of UDP-GlcNAc for D1–352 DmOGT and hOGT were determined in a radiometric in vitro assay
on RBL2 peptide. Triplicate data points were fitted to the Michaelis–Menten equation. Error bars represent the standard error of the mean. (e) Half maximal
inhibitory concentration (IC50) of UDP-5S-GlcNAc on D1–352 DmOGT and hOGT were determined using the radiometric assay with UDP-GlcNAc concentration
equal to the Km for each enzyme. Duplicate data points were fitted to a three-parameter equation for dose-dependent inhibition. ( f,g) The activities of recombinant
D1–352 DmOGT WT and the mutants were determined on RBL2 peptide in vitro using a radiometric assay.
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H596, Y871, K872, K928, H932, R935, H951, D955) that are
found to interact with UDP-GlcNAc and the acceptor peptides
in hOGT are conserved and similarly positioned in DmOGT,
suggesting a similar catalytic mechanism involving the
same UDP-GlcNAc and acceptor peptide binding modes(figure 1b). Sequence conservation on the surface is most
pronounced near the active site (figure 1c). The interven-
ing domain, a 100-amino acid insertion between the two
Rossmann-like folds of the catalytic domain, is the site of
lowest sequence conservation and highest degree of flexibility
in the structures of both hOGT and DmOGT. Three short
rsob.royalsocietypublishing.org
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mirrors that of the hOGT intervening domain (figure 1c).
2.2. Rational design of catalytically impaired DmOGT
mutants
A recent study investigating the substrate sequence require-
ments of hOGT identified a peptide derived from human
retinoblastoma-like protein 2 (RBL2; KENSPCVTPVSTA) as
the best peptide substrate among the 720 Ser/Thr containing
peptides [25]. RBL2 is a retinoblastoma family member—a
family of proteins that are involved in a variety of cellular pro-
cesses including the cell cycle, cell differentiation and apoptosis
[26]. In order to explore the mechanistic similarities between
the hOGT andDmOGT, Michaelis–Menten kinetic parameters
of the D1–352 DmOGT were determined with the RBL2 pep-
tide as an in vitro acceptor substrate in a radiometric assay.
The Michaelis constant (Km) of UDP-GlcNAc for D1–352
DmOGT is 17.8+0.7 mM, similar to the Km of the donor for
D1–312 hOGT (6.6+0.3 mM, figure 1d). A substrate-assisted
glycosyltransfer mechanism has been proposed for hOGT,
wherein a non-bridging oxygen of the a-phosphate of
UDP-GlcNAc serves as the catalytic base [6]. This unique
catalytic mechanism explains the specific inhibition of hOGT
with the thiosugar derivative of the donor substrate, UDP-5S-
GlcNAc [27]. Activity of the D1–352 DmOGT is inhibited by
UDP-5S-GlcNAc with an inhibition constant (Ki) of 36.2 mM,
comparable with the Ki of D1–313 hOGT at 13.6 mM (figure 1e).
This observation further supports the hypothesis that DmOGT
adopts the same catalytic mechanism as hOGT, corroborating
the structural data and Michaelis–Menten kinetics.
To identifyOGTmutantswith a range of catalytic activities,
fourDmOGT point mutants were designed based on the struc-
ture of DmOGT and previous enzymatic studies on hOGT
[6,28,29]. The residue Asp925 in hOGT (DmOGTD955) interacts
with the ribose of the donor substrate (figure 1b) and an alanine
mutant (D925A) has been shown to abolish hOGT enzymatic
activity, primarily by disrupting UDP-GlcNAc binding [29].
Two other point mutants of hOGT, H558F (DmOGTH596F)
and K842M (DmOGTK872M), have been reported to be enzyma-
tically inactive while retaining the ability to bind the donor
substrate UDP-GlcNAc with similar affinity as the wild-type
enzyme [6]. In addition, H498A (DmOGTH537A), a mutant of
a residue that was previously thought to be important for
catalysis, was chosen [5,6]. The D1–352 forms of DmOGTWT
and the DmOGT point mutants were expressed and purified.
Enzymatic activities of these proteins were determined by
a radiometric assay using the RBL2 peptide as acceptor
substrate. D1–352 DmOGTK872M and D1–352 DmOGTD955A
appear to have no catalytic activity even upon extending the
assay to 12 h (figure 1f,g). However, D1–352 DmOGTH537A
and D1–352 DmOGTH596F exhibited 5.6% and 3.0% activity,
respectively, relative to D1–352 DmOGTWT, and thus retained
some degree of catalytic activity (figure 1f,g).
2.3. OGT catalytic activity is essential for early
embryonic development in Drosophila
It has previously been demonstrated that transgenic expression
of wild-type DmOGT in sxc transheterozygotes rescues their
lethality at the pharate adult stage [22]. Using this readout,
the developmental requirements of catalytic versus non-catalytic functions of OGT were dissected (figure 2a). Rescue
of the sxc1/sxc6 pupal lethality was performed by ubiquitously
driving the full-length DmOGTWT or one of the DmOGT point
mutants (H537A, H596F, K872M or D955A) with a tubulin::
GAL4 driver. The details of all the genotypes obtained in
these rescue experiments are outlined in table 2. The rescue
measured with full-length DmOGTWT was in agreement with
the previous report that also used a tubulin::GAL4 driver
[22]. In the absence of this rescue, as is the case with control
crosses lacking either the driver or the transgene, no adult
sxc1/sxc6 transheterozygotes were recovered. Of all the flies
scored from the rescue cross, the fraction of sxc1/sxc6 transheter-
ozygote adults recovered on driving the DmOGTWT form of
OGT ubiquitously was 18.6% (figure 2a and table 2). Given
the crossing scheme, on complete rescue of the lethality pheno-
type, the rescued flies would constitute 20% of total progeny,
which is in agreement with the level of DmOGTWT rescue
observed. The fraction of rescued sxc1/sxc6 transheterozygotes
was 14.7%, 10.5%, 0% and 7.4% when the rescue was
performed with DmOGTH537A, DmOGTH596F, DmOGTK872M
and DmOGTD955A transgenes, respectively (figure 2a,
table 2). Although the flies with the catalytically inactive trans-
gene DmOGTD955A were rescued to adulthood, they had wing
defects ranging from ectopic wing veins, small blisters, notches
to severe blistering (figure 2b,f–h). While a high percentage
(58%) of normal wings (figure 2b,c) were observed in flies res-
cued with the DmOGTWT transgene, 39% of wings had an
ectopic vein (figure 2b). The proportion of flies with ectopic
vein defects in DmOGTH537A, DmOGTH596F and DmOGTD955A
were 59%, 73% and 71%, respectively (figure 2b,d,e). More
severe wing phenotypes were observed in DmOGTD955A res-
cued flies with a sizeable proportion (13%) of them being
completely blistered (figure 2b,f–h). Quantification of the
wing defects in the rescued adult flies revealed a correlation
with the rescue efficiency and catalytic activity of the various
constructs. DmOGT constructs with higher rescue efficiency
had less severe wing phenotypes (figure 2a,b). Crosses
between F1 males and females of the same genotype
(sxc1/sxc6;tub::GAL4/UAS::OGTX, where X ¼WT, H537A,
H596F or D955A) obtained from the rescue crosses yielded
F2 adults except in the case of DmOGTD955A (table 3). To test
whether the lack of F2 adults from the DmOGTD955A rescued
sxc1/sxc6 transheterozygous parents was a result of their
infertility, rescued males/virgin females were crossed to
wild-type virgins/males, respectively. While crosses using
DmOGTD955A rescued sxc1/sxc6 transheterozygote males pro-
duced adult progeny, the crosses with DmOGTD955A rescued
sxc1/sxc6 transheterozygote females only produced a few
larvae that eventually died (table 3).
To probe the level of catalytic activity in the sxc transhe-
terozygotic animals rescued with the various transgenes,
total protein O-GlcNAcylation was assessed by immunoblot-
ting with anti-O-GlcNAc antibody (RL2) (figure 2i). Total
O-GlcNAc levels were significantly reduced in flies rescued
using the DmOGTH537A and DmOGTH596F mutants as
opposed to complete restoration of O-GlcNAcylation in
adults rescued with DmOGTWT. Additionally, there was no
detectable total protein O-GlcNAc in sxc1/sxc6 animals res-
cued with DmOGTD955A (this assay could not be performed
with flies rescued with DmOGTK872M because of the absence
of viable flies). The level of OGT or OGTmut-HA expression
was comparable across the lines (figure 2i). Total protein
O-GlcNAc levels in F2 adults derived from sxc
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Figure 2. Catalytic activity of DmOGT point mutants in flies. (a) Quantification of rescue to adulthood on driving DmOGT transgenes in sxc1/sxc6 mutants.
(b) Quantification of wing phenotypes of sxc1/sxc6 mutant flies rescued by driving the respective DmOGT transgene. Both wings from the rescued flies were assessed
for the following phenotypes: (c) normal wing, (d ,e) ectopic vein, ( f ) notch, (g) bent or (h) blistered. (i) Total lysates from w1118 (WT) or sxc1/sxc6 transheter-
ozygotes expressing the indicated UAS::OGT transgene under the control of tubulin::GAL4 were immunoblotted. The arrowhead points to the specific OGT-HA band.
( j ) Total lysates from w1118 (WT) or sxc/sxc F2 flies derived from crosses between male and female F1 flies expressing the indicated UAS::OGT transgene under the
control of tubulin::GAL4 were prepared and immunoblotted with the respective antibodies. As the F2 flies were derived from parents that are sxc1/sxc6 and hence
could have transheterozygotic (sxc1/sxc6) or homozygotic (sxc1/sxc1 or sxc6/sxc6) genotypes, they are indicated as sxc/sxc.
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Table 2. Rescue of sxc lethality by OGT point mutants. Crosses were set up with ﬂies of the indicated genotypes and transferred into fresh vials every 3–4
days. Adults emerging from the crosses were scored for the presence of second and third chromosome balancers/marker, CyO and MKRS or TM6. Flies that did
not possess any of the balancers/markers (þ;þ) were the rescued sxc1/sxc6 transheterozygotes. Control crosses with ﬂies lacking either the driver
(tubulin::GAL4) or any of the OGT transgenes do not yield any non-CyO adults. n.a., not applicable.
parental cross total adults CyO; TM6 CyO; MKRS CyO; MKRS/TM6 CyO;1 1;1
sxc1/CyO;MKRS/TM6 C  sxc6/CyO; tub::GAL4/TM6 F 512 162 177 173 n.a. 0
sxc1/CyO;UAS::OGTWT C  sxc6/CyO; MKRS/TM6 F 424 178 246 n.a. n.a. 0
sxc1/CyO;UAS::OGTWT C  sxc6/CyO; tub::GAL4/TM6 F 376 226 n.a. n.a. 103 70
sxc1/CyO;UAS::OGTH537A C  sxc6/CyO; tub::GAL4/TM6 F 565 348 n.a. n.a. 134 83
sxc1/CyO;UAS::OGTH596F C  sxc6/CyO; tub::GAL4/TM6 F 462 317 n.a. n.a. 99 46
sxc1/CyO;UAS::OGTK872M C  sxc6/CyO; tub::GAL4/TM6 F 590 459 n.a. n.a. 131 0
sxc1/CyO;UAS::OGTN948I C  sxc6/CyO; tub::GAL4/TM6 F 441 401 n.a. n.a. 40 0
sxc1/CyO;UAS::OGTD955A C  sxc6/CyO; tub::GAL4/TM6 F 495 323 n.a. n.a. 136 36
Table 3. Maternal requirement of OGT catalytic activity. Crosses were set up using rescued F1 ﬂies of the indicated genotypes and scored for the presence (þ)
or absence (2) of F2 adults or larvae. Wild-type males or females were also crossed with OGTD955A rescued ﬂies females or males, respectively to assess
fertility of the F1 adults.
F1 cross F2 larvae adults
sxc1/sxc6; UAS::OGTWT/tub::GAL4 C  sxc1/sxc6; UAS::OGTWT/tub::GAL4 F þ þ
sxc1/sxc6; UAS::OGTH537A/tub::GAL4 C  sxc1/sxc6; UAS::OGTH537A tub::GAL4 F þ þ
sxc1/sxc6; UAS::OGTH596F/tub::GAL4 C  sxc1/sxc6; UAS::OGTH596F/tub::GAL4 F þ þ
sxc1/sxc6; UAS::OGTD955A/tub::GAL4 C  sxc1/sxc6; UAS::OGTD955A/tub::GAL4 F 2 2
sxc1/sxc6; UAS::OGTD955A/tub::GAL4 C  w1118 F þ 2
w1118 C  sxc1/sxc6; UAS::OGTD955A/ tub::GAL4 F þ þ
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DmOGTH596F were comparable with that of the F1 rescues
(figure 2j). To determine the specificity of the signals obtained
using the O-GlcNAc antibody (RL2), total WT fly lysates were
incubated with CpOGA, a potent enzyme that is known to
remove O-GlcNAc from proteins [30,31]. CpOGA treatment
revealed that the prominent 100 kDa and lower molecular
weight proteins are non-specific signals detected in the assay
(electronic supplementary material, figure S1A). In addition,
competition with 0.5 M GlcNAc during primary antibody incu-
bation confirmed the specificity of RL2 reactivity (electronic
supplementary material, figure S1B). These control experiments
confirm that the O-GlcNAc-specific reactivity of RL2 is to
proteins greater than 60 kDa.
sxc has shown to be involved in Polycomb dependent
derepression of Hox genes [32]. As observations can be con-
founded by the presence of maternal OGT products in the F1
embryos or larvae, phenotypes were assessed in F2 embryos.
The F2 embryos are sxc1 homozygotes, sxc6 homozygotes or
sxc1/sxc6 transheterozygotes. Nevertheless, it is not possible to
determine the precise sxc genotype on the second chromosome
in these embryos. By immunostaining for the HA tag, the
embryos expressing the respective OGT transgene can be ident-
ified and all experiments in rescued F2 embryos described
further are in embryos expressing the respective DmOGT trans-
gene. O-GlcNAc levels were assessed in F2 embryos using the
RL2 antibody. While O-GlcNAc levels in DmOGTWT rescued
embryos were comparable with those in w1118 embryos, faintimmunostaining in cells overexpressing DmOGTH537A was
observed (figure 3a–c). However, no O-GlcNAc staining could
be observed in embryos rescued with either DmOGTH596F or
DmOGTD955A (figure 3d,e). As sxc mutants display phenotypes
similar to PcG genes that are involved in Hox gene repression,
expression patterns of the Hox genes, Sex combs reduced (Scr),
Ultrabithorax (Ubx) and Abdominal-B (Abd-B) were assessed by
immunostaining. Expression patterns of Ubx (figure 3k–o) and
Scr (figure 3p–t) remained unchanged in F2 embryos rescued
with any of the DmOGT transgenes and were comparable with
the wild-type pattern. Interestingly, Abd-B was de-repressed
anterior to its normal expression domain in most of the
DmOGT-D955A rescued F2 embryos (figure 3j). The Abd-B
expression pattern was unaltered in all DmOGTWT and most
of the DmOGTH537A and DmOGTH596F rescued embryos
(figure 3f– i).3. Discussion
The role of sxc as a PcG gene that functions in homeotic gene
repression in Drosophila has been established [21]. The homeo-
tic transformation and lethality phenotypes of sxc have been
ascribed to the catalytic glycosyltransferase activity of OGT
[20,22,32], but OGT is a large multi-domain protein known to
participate in numerous protein–protein interactions [9–12].
We aimed to dissect the requirement of OGT catalytic activity
during Drosophila development using a hypomorphic
(a) (b) (c) (d ) (e) DAPI
w1118 sxc/sxc;UAS::OGTWT/tub::GAL4 sxc/sxc;UAS::OGTH537A/tub::GAL4 sxc/sxc;UAS::OGTH596F/tub::GAL4 sxc/sxc;UAS::OGTD955A/tub::GAL4
HA O-GlcNAc
DAPI HA Abd-B
DAPI HA Ubx
DAPI HA Scr(p) (q) (r) (s) (t)
(k) (l) (m) (n) (o)
( f ) (g) (h) (i) ( j)
Figure 3. Repression of Hox genes in DmOGT point mutant-rescued F2 embryos. Stage 9–11 (a– e) or stage 13–14 ( f– t) F2 embryos were immunostained with
O-GlcNAc (RL2; a– e), Abd-B ( f– j ), Ubx (k–o) or Scr ( p– t) antibodies. F2 embryos from w1118 (a,f,k,p) or crosses between F1 siblings with the following
genotypes were collected, fixed and immunostained: sxc1/sxc6;UAS::OGTWT/tub::GAL4 (b,g,l,q), sxc1/sxc6;UAS::OGTH537A/tub::GAL4 (c,h,m,r), sxc1/sxc6;UA-
S::OGTH596F/tub::GAL4 (d,i,n,s) and sxc1/sxc6;UAS::OGTD955A/tub::GAL4 (e,j,o,t). White arrowheads indicate derepression of Abd-B in sxc/sxc;UAS::OGTD955A/
tub::GAL4 embryos ( j ).
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by X-ray crystallography, revealing that the overall fold and
domain architecture of DmOGT closely mirrors that of hOGT.
The degree of flexibility of individual domains of OGT has
been the subject of some speculation [5]. Central to this specu-
lation is the assumption that OGT modifies intact, fully folded
and predominantly large protein substrates. And yet, in the
available structures of hOGT, the active site is not very accessi-
ble, being partly occluded by the TPR domain. This has led to
the hypothesis of a ‘hinge-like movement’ between TPRs
12 and 13 that would expose the active site [5]. While such a
substrate-induced conformational change cannot be excluded,
the current structural evidence shows OGTs of three species
(bacterial [29], human andD. melanogaster) adopting very simi-
lar conformations with limited access to the active site. In the
absence of a complex between OGT and an entire protein, the
question of substrate access remains unresolved.
The almost complete identity of sequence and structure in
the active site of DmOGT and hOGT suggested a similar cata-
lytic mechanism and that any differences in substrate
specificity are most probably attributable to regions of lower
conservation beyond the active site. The largely unexplored
intervening domain has the least structural similarity between
hOGT and DmOGT. We also noticed a higher degree of dis-
order in this part of the structure. If the intervening domain
was involved in the recruitment of protein substrates, it
would explain the flexibility we observed in the absence of a
binding partner. A key observation from the sequence com-
parison of DmOGT to hOGT is the non-conservation of the
C-terminal array of lysines, which in hOGT was proposed to
bind PIP3 and hence mediate translocation of hOGT to the
plasma membrane upon insulin stimulation [33]. However, it
has been recently reported that hOGT does not bind PIP3 [5].
The absence of a similar positively charged patch on the surface
ofDmOGT furtherweakens the hypothesis that PIP3 binding in
general could regulate the subcellular localization of OGT.Analysis of DmOGT and hOGT structures guided the design
of several OGT point mutants that were found to possess vary-
ing degrees of catalytic activities with DmOGTK872M and
DmOGTD955A activities being undetectable. These mutations,
by virtue of possessing almost no catalytic activity, provided
tools to examine the role of OGT catalysis.
The TPR regions of OGT are better conserved than the rest
of the protein. In keeping with this motif as a protein–protein
interaction domain, there are several examples of OGT sub-
strates interacting with the OGT TPR domain. Nevertheless,
there are also examples of OGT catalytic domain-dependent
binding of substrates. However, instances of OGT performing
a scaffolding function completely independent of its catalytic
activity are not known. Ectopic expression of the TPR domain
was carried out in Arabidopsis spindly (spy) alleles, where
lesions in TPRs are associated with gibberellin signalling
defects [34]. However, it was reported that the TPR domain
alone could not rescue the spy phenotype. When expressed
in a wild-type background, the TPR domain mimics spy
phenotypes, implicating that it disrupts interaction, oligomer-
ization or localization of endogenous full-length SPINDLY
[34]. Given that TPRs form the most prominent structural fea-
ture other than the catalytic core, OGT could also perform a
non-enzymatic, scaffolding/adapter function as has been
demonstrated for many other TPR proteins [35–38]. Neverthe-
less, one or more of the proteins assembling into such
complexes could also be OGT substrates, thus complicating
the dissection of these two functions. The only non-O-
GlcNAc transfer role described for OGT is of aiding proteolysis
of HCF1 and is dependent on the presence of the TPR domain
as well as O-GlcNAcylation of HCF1 [39,40]. Notably, the key
catalytic residue important forO-GlcNAc transfer, K842, is also
essential for OGT proteolytic activity against HCF1.
Rescue of sxc pupal lethality is in agreement with a pre-
vious study [22] on rescuing with DmOGTWT. While both
DmOGTK872M and DmOGTD955A possess no detectable
rsob.royalsocietypublishing.org
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in animals overexpressing DmOGTD955A. Mutant forms of the
equivalent residues in hOGT (K842M and D925A) have been
shown to be inactive in vitro against peptide substrates [29,39].
Whereas hOGTK842M can bind UDP-GlcNAc with similar affi-
nity as the wild-type, hOGTD925A was proposed to be deficient
in donor substrate binding [29]. The difference in the rescue
potential of DmOGTK872M and DmOGTD955A may be due to
undetectably low activity ofDmOGTD955A. It therefore appears
that adult Drosophila can survive with extremely low OGT cat-
alytic activity. No F2 adults could be derived from sxc flies
rescued with DmOGTD955A outlining the developmental
requirement for catalytic activity in the absence of maternal
products. However, minimal levels of OGT activity were suffi-
cient to overcome this requirement, as evidenced by F2
progeny produced by DmOGTH596F sxc rescues.
Wing phenotypes in rescued F1 adults correspond to the
level of OGT activity of the rescue construct, with reduced
activity corresponding to more severe phenotypes. The most
prevalent defect observed was for ectopic vein arising from
the posterior cross-vein in rescues with almost all the con-
structs. Interestingly, similar ectopic vein phentotype, arising
from the posterior cross-vein, is observed in Drosophila HCF
(dHCF) mutants [41]. With dHCF being an OGT substrate, it
is possible that sub-optimal O-GlcNAcylation of dHCF leads
to the ectopic vein phenotype. Given that more than half of
flies rescued even with DmOGTWT exhibit the ectopic vein
phenotype, it implies that this phenotype is sensitive to precise
levels of O-GlcNAcylation of an OGT substrate, possibly
dHCF. Interestingly, other phenotypes observed in dHCF
mutants [41] are not replicated in the rescued F1 adults.
Homeotic transformations in sxc mutants and the loss of
PcG repression in larval imaginal discs have been demon-
strated [20,21]. In Drosophila, components of polycomb
repressive complex 1 (PRC1), a PcG complex, were found to
be O-GlcNAcylated while the assembly of PRC2 was found
to be upstream of O-GlcNAcylation in mouse ES cells
[20,42]. More recently, however, it has been demonstrated
in MCF-7 cells that the protein stability of EZH2, the histone
methyl transferase component of PRC2, was dependent on its
O-GlcNAcylation [43]. Nevertheless, recruitment of PRC pro-
teins to DNA is not dependent on O-GlcNAcylation in
Drosophila [20]. O-GlcNAcylation of YY1, a PcG protein, is
essential for its interaction with retinoblastoma protein and
hence transcriptional control by YY1 [44]. Polyhomeotic
(Ph), a PcG protein, co-localizes with O-GlcNAcylation in
polytene chromosomes and its recruitment to DNA at poly-
comb response elements is reduced in sxc mutants [20,22].
It has been demonstrated that when a Ser/Thr rich stretch
in Ph is deleted, Abd-B is de-repressed, a phenotype also
observed in sxcmat,zyg embryos [32]. Interestingly, Ubx,
another Hox gene which was also reported to be de-repressed
in sxcmat,zyg embryos [32], retains its normal domain of
expression in the F2 embryos rescued with any of the
DmOGT transgenes in this study (figure 2k–o). This suggests
that different mechanisms are possibly adopted by OGT to
repress different Hox genes. Abd-B repression probably
requires relatively higher OGT catalytic function as compared
to repression of the other Hox genes.
In summary, we sought to determine the requirement for
protein O-GlcNAcylation in Drosophila development. Rescue
experiments in sxcmutants suggest the requirement ofOGT cat-
alytic activity up to early larval development. Theseexperiments also demonstrate an extremely reduced require-
ment of OGT catalysis in pupal/adult stages. Association of
the severity of wing phenotypes with reduced OGT activity
implies a role for O-GlcNAcylated substrates in wing develop-
ment. Embryos lacking maternal OGT catalytic activity, and
consequently possessing significantly reduced O-GlcN-
Acylated substrates in the embryo, also display de-repression
of only a subset of Hox genes. While these results underline
the importance of OGT catalysis for Drosophila embryonic
and larval development, it is intriguing that further develop-
ment occurs almost independent of OGT catalytic activity.
The possibility that non-catalytic OGT function(s) are essential
in the adult remains unexplored.4. Material and methods
4.1. Expression and purification of DmOGT constructs
DmOGTD1–352 K872M was expressed in ArcticExpress E. coli
and purified as described for hOGTD1–312 [6].
4.2. Crystallization
Protein used in crystallization was stored in 25 mM Tris–HCl,
pH 7.5, 150 mM NaCl and 2 mM DTT. D1–352 DmOGTK872M
was crystallized in complex with UDP-5S-GlcNAc. Vapour
diffusion crystallization experimentswith sitting drops contain-
ing 0.2 ml protein (at 10 mg ml21 in a buffer of 25 mMTris–HCl
pH 7.5, 150 mM NaCl, 2 mM DTT, 3 mM UDP-5S-GlcNAc)
and 0.2 ml reservoir solution (condition 70 of the Molecular
Dimensions Morpheus screen: 0.12 M mix of D-glucose,
D-mannose, D-galactose, L-fucose, D-xylose, N-acetyl-D-
glucosamine, 30% PEG8000/ethylene glycerol and 0.1 M
Tris–Bicine pH 8.5) gave needle-shaped crystals after 1–2
days at 218C. The crystals were flash-frozen without further
cryoprotection. Data were collected at the European Synchro-
tron Radiation Facility, Grenoble, France, on beamline ID29.
Crystals belonged to space group P32 and contained 3 mol-
ecules per asymmetric unit. The structure was solved by
molecular replacement with MOLREP [45] using the A chain
of PDB ID 3PE4 and refined using iterative model building
and refinement with COOT [46] and REFMAC5 [47] (table 1).
4.3. Enzyme kinetics on hOGT and DmOGT
Steady–state kinetics was performed with the acceptor peptide
KENSPCVTPVSTAusing a radiometric assay. Assayswere con-
ducted in a final reaction volume of 20 ml containing 50 nM
hOGT (D1–312) or 100 nM DmOGT (D1–352), 0.25 mM RBL2
peptide and UDP-GlcNAc (100 mM, 50 mM, 20 mM, 5 mM,
2 mM, 0.5 mM and 0.05 mM) with final 0.3 Ci mmol21 UDP-
[3H]-GlcNAc as a radioactive tracer, in buffer containing
100 mM Tris–HCl, pH 7.5, 150 mM NaCl and 1 mM DTT. The
reaction was stopped by addition of 200 ml of 0.75 M ice-cold
phosphoric acid containinga final concentration of 0.5% trifluor-
oacetic acid (TFA) and 5% acetonitrile (ACN). A C18 column
was activated by 200 ml 100% methanol and equilibrated twice
with 200 ml of equilibration buffer containing 0.5% TFA and
5%ACN. Sampleswere passed through the C18 columnby cen-
trifugation at 500 r.p.m. for 30 s and columns were washed six
times with 400 ml equilibration buffer. Peptide bound to the
column was eluted by the addition of 100 ml 100% methanol
rsob.royalsocietypublishing.org
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detected by the addition of 4 ml scintillation fluid and signal
was read by a scintillation counter. Triplicate data points were
fitted to the Michaelis–Menten equation. Experiments to deter-
mine the half maximal inhibitory concentration (IC50) for UDP-
5S-GlcNAc was performed as described above with UDP-
GlcNAc concentrations fixed at the respective Km for hOGT
(5 mM) and DmOGT (15 mM). Duplicate data points were
fitted to a three-parameter equation for dose-dependent inhi-
bition. The inhibition constants (Ki) of UDP-5S-GlcNAc for
both proteins were approximated by the Cheng–Prusoff
equation.en
Biol.5:1502344.4. Drosophila genetics, wing preparations and
immunostaining
The following stocks from Bloomington Drosophila Stock
Center were used: w1118, sxc1/CyO, sxc6/CyO and tub::GAL4/
TM6. Transgenic flies were generated by Rainbow Transgenic
Flies, Inc., California with the attP insertion site at 86F8.
Rescue experiments were performed by crossing sxc1/CyO
(Kr::GFP);UAS::OGTX(X ¼ either WT, H537A, H596F,
K872M or D955A) and sxc1/CyO (Kr::GFP);tub::GAL4/TM3
(twi::GAL4, UAS::2XEGFP), Sb, Ser flies. Rescued F1 flies of
the genotype sxc1/sxc6;UAS::OGTX/tub::GAL4 (X ¼ either
WT, H537A, H596F or D955A) were assessed for thewing phe-
notypes or snap frozen for western blotting. Apart from wild-
type wings, phenotypes included ectopic veins, notch, bent or
blistered wings. Wings from rescued F1 sxc1/sxc6;UAS::OGTX/
tub::GAL4 (X ¼ either WT, H537A, H596F or D955A) adults
were removed and transferred into isopropanol for 24 h. The
wings were then mounted using DPX mounting medium
(Fisher Scientific) after allowing for evaporation of isopropa-
nol. Images were acquired using a dissection microscope
after the medium was allowed to harden overnight. Fixing
and immunostaining of embryos was performed as descri-
bed previously [48]. The following antibodies were used:
mouse anti-O-GlcNAc (1 : 250,RL2, Abcam), sheep anti-HA
(1 : 500) and mouse antibodies from Developmental Studies
Hybridoma Bank: anti-Scr (1 : 50), anti-Abd-B (1 : 50) and
anti-Ubx (1 : 50) with the respective fluorescent secondary anti-
bodies (Invitrogen). Microscopic images were obtained with aZeiss 710 confocal microscope and processed using VOLOCITY
(Improvision) software.
4.5. Western blotting
For western blots, five anaesthetized adult flies were frozen on
dry ice. The frozen flies were homogenized in 50 ml of lysis
buffer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1% Triton-
X-100, 1 mM GlcNAcstatin C, 5 mM sodium fluoride, 2 mM
sodium orthovanadate, 1 mM benzamidine, 0.2 mM PMSF,
5 mM leupeptin and 1 mM DTT), following which an equal
volume of three times SDS Laemmli buffer was added. Lysates
were then heated for 5 min at 958C, centrifuged at 16 000g for
10 min and supernatants were collected. Protein concentrations
were estimated using the 660 nm protein assay (Thermo
Scientific). Thirtymicrograms of the crude lysatewere subjected
to SDS-PAGE and transferred onto nitrocellulose membrane
before immunoblotting with RL2 (1 : 1000), rabbit anti-OGT
(H-300, 1 : 1000, SantaCruz Biotech), mouse anti-HA (1 : 5000,
12CA5) and/or anti-actin (1 : 5000, Sigma) and the respective
infrared dye conjugated secondary antibodies (Li-Cor or Life
Technologies, 1 : 10 000). To determine the specificity of the
O-GlcNAc signal with the RL2 antibody,w1118 adult fly lysates
were treated with CpOGA [30] for 30 min at 308C before pro-
cessing for western blotting. Alternatively, the RL2 antibody
incubations were carried out in the presence of 0.5 M GlcNAc.
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